Also known as Omnicef and Omnicef Omni-Pac
Cefdinir is a third generation oral cephalosporin antibiotic. It was discovered by Fujisawa Pharmaceutical Co., Ltd. "Fujisawa" (now Astellas) and introduced in 1991 under the brand name Cefzon. Warner-Lambert licensed this cephalosporin, cefdinir, for marketing in US from Fujisawa, Japan. Abbott obtained U.S. marketing rights to Omnicef (Cefdinir) in December 1998 through an agreement with Warner-Lambert Company. It was approved by FDA on Dec 4, 1997. It is available in US as Omnicef by Abbott Laboratories and in India as Cednir by Abbott and Cefdiel by Ranbaxy.Source: Wikipedia
Estimated Total Cost: $37.27 for an average of 7 days supply
Patients are most commonly prescribed cefdinir to treat otitis media, nasal congestion, ear pain, and chronic sinusitis.